These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19286260)

  • 1. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.
    Beernink PT; LoPasso C; Angiolillo A; Felici F; Granoff D
    Mol Immunol; 2009 May; 46(8-9):1647-53. PubMed ID: 19286260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.
    Giuntini S; Beernink PT; Reason DC; Granoff DM
    PLoS One; 2012; 7(3):e34272. PubMed ID: 22461909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.
    Beernink PT; Granoff DM
    Infect Immun; 2008 Jun; 76(6):2568-75. PubMed ID: 18362128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.
    Beernink PT; Welsch JA; Bar-Lev M; Koeberling O; Comanducci M; Granoff DM
    Infect Immun; 2008 Sep; 76(9):4232-40. PubMed ID: 18591239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp.
    Vu DM; Pajon R; Reason DC; Granoff DM
    Sci Rep; 2012; 2():341. PubMed ID: 22461972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
    Welsch JA; Ram S; Koeberling O; Granoff DM
    J Infect Dis; 2008 Apr; 197(7):1053-61. PubMed ID: 18419542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6.
    Bianchi F; Veggi D; Santini L; Buricchi F; Bartolini E; Lo Surdo P; Martinelli M; Finco O; Masignani V; Bottomley MJ; Maione D; Cozzi R
    FASEB J; 2019 Nov; 33(11):12099-12111. PubMed ID: 31442074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.
    van der Veen S; Johnson S; Jongerius I; Malik T; Genovese A; Santini L; Staunton D; Ufret-Vincenty RL; Pickering MC; Lea SM; Tang CM
    Infect Immun; 2014 Mar; 82(3):1157-63. PubMed ID: 24379280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
    Faleri A; Santini L; Brier S; Pansegrau W; Lo Surdo P; Scarselli M; Buricchi F; Volpini G; Genovese A; van der Veen S; Lea S; Tang CM; Savino S; Pizza M; Finco O; Norais N; Masignani V
    FASEB J; 2014 Apr; 28(4):1644-53. PubMed ID: 24371123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
    Vu DM; Wong TT; Granoff DM
    Vaccine; 2011 Feb; 29(10):1968-73. PubMed ID: 21241734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.
    Giuntini S; Reason DC; Granoff DM
    Infect Immun; 2012 Jan; 80(1):187-94. PubMed ID: 22064712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
    Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.
    Johnson S; Tan L; van der Veen S; Caesar J; Goicoechea De Jorge E; Harding RJ; Bai X; Exley RM; Ward PN; Ruivo N; Trivedi K; Cumber E; Jones R; Newham L; Staunton D; Ufret-Vincenty R; Borrow R; Pickering MC; Lea SM; Tang CM
    PLoS Pathog; 2012; 8(10):e1002981. PubMed ID: 23133374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
    Veggi D; Bianchi F; Santini L; Lo Surdo P; Chesterman CC; Pansegrau W; Bechi N; Huang Y; Masignani V; Pizza M; Rappuoli R; Bottomley MJ; Cozzi R; Maione D
    PLoS Pathog; 2020 Oct; 16(10):e1008882. PubMed ID: 33007046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.
    Malito E; Faleri A; Lo Surdo P; Veggi D; Maruggi G; Grassi E; Cartocci E; Bertoldi I; Genovese A; Santini L; Romagnoli G; Borgogni E; Brier S; Lo Passo C; Domina M; Castellino F; Felici F; van der Veen S; Johnson S; Lea SM; Tang CM; Pizza M; Savino S; Norais N; Rappuoli R; Bottomley MJ; Masignani V
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3304-9. PubMed ID: 23396847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.
    Giuntini S; Reason DC; Granoff DM
    Infect Immun; 2011 Sep; 79(9):3751-9. PubMed ID: 21708990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
    Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
    J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.
    Pajon R; Beernink PT; Granoff DM
    Infect Immun; 2012 Aug; 80(8):2667-77. PubMed ID: 22615247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.